Last update 05 Jul 2025

Budesonide/Carmoterol Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Budesonide/carmoterol, Carmoterol/budesonide, CHF-5188
Target
GR x β2-adrenergic receptor
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Therapeutic Areas
Immune System DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
Persistent asthma
Originator Organization
CHIESI Farmaceutici SpACHIESI Farmaceutici SpA
Active Organization-
Inactive Organization
CHIESI Farmaceutici SpACHIESI Farmaceutici SpA
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC21H25ClN2O4
InChIKeySYCWERNQGSKYAG-QVRIGTRMSA-N
CAS Registry137888-11-0
View All Structures (2)

Related

2
Clinical Trials associated with Budesonide/Carmoterol Hydrochloride
NCT01070524
/ CompletedPhase 2
A Randomised, Double-blind, Active-controlled, 3 Way Cross-over Study to Evaluate the Effect on Trough FEV1 After 4 Weeks Treatment With CHF 5188 pMDI qd (Fixed Combination Budesonide / Carmoterol) in Adult Patients With Moderate or Severe Persistent Asthma
EUCTR2007-000774-23-GB
/ Not yet recruitingNot Applicable
EVALUATION OF CARDIAC SAFETY, TOLERABILITY AND EFFICACY OF CUMULATIVE DOSES OF CHF5188 pMDI (FIXED COMBINATION BUDESONIDE/CARMOTEROL 200/1 µg) COMPARED TO SAME CUMULATIVE DOSES OF CARMOTEROL pMDI AND PLACEBO IN ASTHMATIC PATIENTSA MONOCENTER, RANDOMISED, DOUBLE-BLIND, 3-WAY, CROSS-OVER CLINICAL STUDY
100 Clinical Results associated with Budesonide/Carmoterol Hydrochloride
Login to view more data
100 Translational Medicine associated with Budesonide/Carmoterol Hydrochloride
Login to view more data
100 Patents (Medical) associated with Budesonide/Carmoterol Hydrochloride
Login to view more data
100 Deals associated with Budesonide/Carmoterol Hydrochloride
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Persistent asthmaPhase 2
United Kingdom
CHIESI Farmaceutici SpACHIESI Farmaceutici SpA
01 Jan 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free